epiroprim has been researched along with sulfadiazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dankert, W; Hartman, PG; Mehlhorn, H; Then, RL | 1 |
| Allegra, CJ; Kovacs, JA; Martinez, A | 1 |
2 other study(ies) available for epiroprim and sulfadiazine
| Article | Year |
|---|---|
A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Female; Folic Acid Antagonists; Male; Mice; Mice, Inbred Strains; Mice, Nude; Mice, SCID; Pilot Projects; Pneumocystis; Pneumocystis Infections; Pyrimethamine; Rats; Rats, Nude; Sodium Chloride; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim | 1995 |
Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Half-Life; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Sulfadiazine; Toxoplasmosis, Animal; Trimethoprim | 1996 |